EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors

Cancer Research and Treatment ◽

10.4143/crt.2017.378 ◽

2018 ◽

Vol 50 (3) ◽

pp. 908-916 ◽

Author(s):

Jiyoul Yang ◽

Ok-Jun Lee ◽

Seung-Myoung Son ◽

Chang Gok Woo ◽

Yusook Jeong ◽

...

Keyword(s):

Pleural Effusion ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Malignant Pleural Effusion ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Mutation Status ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

Current Drug Discovery Technologies ◽

10.2174/1570163813666160524142846 ◽

2016 ◽

Vol 13 (2) ◽

pp. 68-76 ◽

Author(s):

Akash Verma ◽

Akhil Chopra ◽

Yeo W. Lee ◽

Lavina D. Bharwani ◽

Atasha B. Asmat ◽

...

Keyword(s):

Pleural Effusion ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Malignant Pleural Effusion ◽

Kinase Inhibitors ◽

Talc Pleurodesis ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Effectiveness of EGFR-tyrosine kinase inhibitors (TKI) versus EGFR-TKIs plus talc pleurodesis in preventing recurrence of malignant pleural effusion (MPE) in advanced lung adenocarcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e21684 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e21684-e21684

Author(s):

Akash Verma ◽

Akhil Chopra ◽

John Abisheganaden

Keyword(s):

Pleural Effusion ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Malignant Pleural Effusion ◽

Kinase Inhibitors ◽

Talc Pleurodesis ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Download Full-text

Discordance of EGFR mutation status between primary lung adenocarcinomas and corresponding metastatic tumors and the sensitivity to EGFR tyrosine kinase inhibitors

Annals of Oncology ◽

10.1093/annonc/mdw383.48 ◽

2016 ◽

Vol 27 ◽

pp. vi430

Author(s):

H.S. Han ◽

J. Yang ◽

M.K. Choi ◽

J. Kwon ◽

K.H. Lee ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Metastatic Tumors ◽

Mutation Status ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Lung Adenocarcinomas

Download Full-text

P3.01-29 St.Iv Lung Adenocarcinoma Treated by First-Line EGFR–Tyrosine Kinase Inhibitors-Survival, EGFR Mutation, Histologic Subtype

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1589 ◽

2018 ◽

Vol 13 (10) ◽

pp. S878

Author(s):

T. Gil ◽

G. Czyżewicz ◽

M. Skoczek ◽

P. Wójcik ◽

P. Hajder ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Histologic Subtype ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

.EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research

Pharmacological Research ◽

10.1016/j.phrs.2021.105583 ◽

2021 ◽

pp. 105583

Author(s):

Rui-Fang Dong ◽

Miao-Lin Zhu ◽

Ming-Ming Liu ◽

Yi-Ting Xu ◽

Liu-Liu Yuan ◽

...

Keyword(s):

Tyrosine Kinase ◽

Clinical Research ◽

Tyrosine Kinase Inhibitors ◽

Molecular Mechanisms ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

V843I, a Lung Cancer Predisposing EGFR Mutation, Is Responsible for Resistance to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000241 ◽

2014 ◽

Vol 9 (9) ◽

pp. 1377-1384 ◽

Author(s):

Satsuki Matsushima ◽

Kouki Ohtsuka ◽

Hiroaki Ohnishi ◽

Masachika Fujiwara ◽

Hiroyuki Nakamura ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitors

Thoracic Cancer ◽

10.1111/1759-7714.12814 ◽

2018 ◽

Vol 9 (9) ◽

pp. 1151-1155 ◽

Author(s):

Zhansheng Jiang ◽

Yu Zhang ◽

Yinli Yang ◽

Zhensong Yue ◽

Zhanyu Pan

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Abstract 742: Effect of Hsp90 inhibitor NVP-AUY922 with radiation on lung adenocarcinoma cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

10.1158/1538-7445.am2015-742 ◽

2015 ◽

Author(s):

Yuho Maki ◽

Shinsuke Hashida ◽

Hiromasa Yamamoto ◽

Kazuhiko Shien ◽

Tomoaki Ohtsuka ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Hsp90 Inhibitor ◽

Adenocarcinoma Cell ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

An activation of LC3A-mediated autophagy contributes tode novoand acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma

The Journal of Pathology ◽

10.1002/path.4354 ◽

2014 ◽

pp. n/a-n/a ◽

Author(s):

Kaito Nihira ◽

Yasuhiro Miki ◽

Shinya Iida ◽

Sodai Narumi ◽

Katsuhiko Ono ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Acquired Resistance to EGFR Tyrosine Kinase Inhibitors is Associated With Low Efficacy of Radiation Therapy for Brain Metastases From EGFR-mutant Lung Adenocarcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.166 ◽

2012 ◽

Vol 84 (3) ◽

pp. S102

Author(s):

H. Hirata ◽

K. Nakamura ◽

N. Kunitake ◽

Y. Shioyama ◽

T. Sasaki ◽

...

Keyword(s):

Radiation Therapy ◽

Brain Metastases ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Download Full-text